LMT

LMT - Lockheed Martin Corp

BUYAWAIT ENTRYIndustrials ยท Aerospace & Defense2026-08-01Updated todayUSD 582.74
67
Conviction
out of 100

Executive Summary

Lockheed Martin Corp is a US prime defence contractor, headquartered in Bethesda, Maryland, organised across four business segments - Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space - and is the principal supplier of the F-35 Lightning II, the PAC-3 missile defence interceptor, and the Orion crew vehicle for NASA's Artemis programme. It is the largest defence company by revenue in the United States and holds long-standing sole-source positions on several classified and export-controlled platforms.

The investment case rests on the conversion of the USD58.62 billion PAC-3 contract and multi-year munitions framework agreements into recognised revenue, supported by the reaffirmed full-year 2026 guidance issued at the Q1 2026 results on 22 April 2026 and by management continuity following the appointment of OJ Sanchez as president of the Aeronautics business on 1 June 2026. The principal risk is execution slippage or further free-cash-flow deterioration on the F-35 programme, where risks are explicitly disclosed in the 10-K.

BUY. Conviction Score: 67/100. The view would shift towards HOLD on a confirmed F-35 sustainment-cost overrun, a breach of the FY26 net sales guidance of mid-single-digit growth, or a sustained reduction in NATO munitions demand.

Business Model

Lockheed Martin generates revenue predominantly through long-cycle US Department of Defence procurement contracts and, increasingly, foreign military sales channelled through the US government. The contract base is heavily weighted towards sole-source and limited-competition platforms - F-35 sustainment and follow-on lots, PAC-3 interceptors, THAAD, Sikorsky rotorcraft, and a portfolio of classified programmes reported within Aeronautics and Rotary and Mission Systems. Reported FY25 group sales were USD60.0 billion, of which Aeronautics contributed approximately 39 percent, Missiles and Fire Control 21 percent, Rotary and Mission Systems 27 percent, and Space 13 percent, with US government customers accounting for the substantial majority of consolidated revenue.

Backlog visibility is the central operating feature of the model. Lockheed ended Q1 2026 with a total backlog of approximately USD174 billion, providing multi-year cover against the USD60 billion annual revenue base and limiting near-term order-book risk. Operating margins sit in the low double digits, with Q1 2026 segment operating margin reported at 9.8 percent; reported diluted EPS for Q1 2026 was USD6.51, down on the prior-year quarter alongside negative free cash flow of USD1.2 billion for the period. The company has historically returned the majority of free cash flow to shareholders via dividends and buybacks, and capital return remains a core part of the investment proposition.

The competitive moat derives from three reinforcing factors: intellectual property and tooling lock-in on the F-35 sustainment franchise; certified interceptor integration and propellant supply on PAC-3 and THAAD; and the security clearance base and programme management infrastructure required to deliver classified US government work. Each factor raises the switching cost for any alternative supplier and supports the long-duration backlog that defines the equity story.

Financial Snapshot

Price
USD 582.74
Market Cap
USD 134.5bn
P/E Ratio
21.5x
52w High
USD 692.00
52w Low
USD 417.00
Distance from 52wH
-15.8%
Beta
0.11
Avg Volume
1380158
Currency
USD

Recent Catalysts

[January 2026] - Lockheed Martin filed a Form 8-K on 29 January 2026 disclosing a reportable corporate event under Section 13 or 15(d) of the Securities Exchange Act of 1934, with the company's principal office listed at 6801 Rockledge Drive, Bethesda, Maryland. Source: SEC Form 8-K filing.

[Q1 2026 (results reported 22 April 2026)] - Lockheed Martin reaffirmed its full-year 2026 guidance of mid-single-digit sales growth and confirmed earnings and net sales outlooks, sending the shares up 4.6 percent on the day. Source: RTTNews.

[May 2026] - Lockheed Martin announced the appointment of OJ Sanchez as president of its approximately USD30 billion Aeronautics business, succeeding Greg Ulmer effective 1 June 2026. Source: Lockheed Martin press release, 6 May 2026 (PRNewswire).

[Prior to 2026-08-01] - Lockheed Martin secured a USD58.62 billion PAC-3 contract and entered multi-year munitions framework agreements, providing hard revenue catalysts against the reaffirmed 2026 outlook. Source: Company contract announcements referenced in publicly available defence industry reporting.

[Q2 2026] - Q2 2026 earnings were reported on 23 April 2026 according to public earnings calendars; the report was the most recent quarterly print available at the time of writing. Source: Meyka earnings calendar note, 23 April 2026.

Thesis Evaluation

Bull Case (36% weight)

The PAC-3 contract ramps into recognised revenue through 2027, F-35 sustainment margins stabilise after the TR-3 software cutover, and NATO munitions demand remains elevated into the late 2020s, allowing Lockheed Martin to compound sales at the upper end of its mid-single-digit range while restoring free cash flow to historical norms. Lockheed Martin's defensive platforms continue to capture share within rising allied defence budgets and the classified portfolio contributes outsized margin. Price target: USD660 over a 12-month horizon.

Base Case (48% weight)

Lockheed Martin executes against reaffirmed FY26 guidance of mid-single-digit sales growth, delivers modest margin recovery from the Q1 2026 trough, and converts the existing backlog into steady cash returns while FCF rebuilds gradually through the second half of 2026. Aeronautics leadership transition completes cleanly under OJ Sanchez and no major F-35 programme disruption is disclosed in subsequent filings. Price target: USD610 over a 12-month horizon.

Bear Case (16% weight)

F-35 sustainment costs overrun the disclosure already itemised in the 10-K, PAC-3 deliveries slip against the USD58.62 billion schedule, and free cash flow fails to normalise from the negative USD1.2 billion reported in Q1 2026, forcing the dividend under review and compressing the multiple towards historical trough levels. Price target: USD470 over a 12-month horizon.

Weighted conviction:Bull (36%) x 100 + Base (48%) x 62 + Bear (16%) x 10 = 67/100. BUY.

Key Risks

  1. F-35 sustainment cost overrun: Cost or schedule overruns on F-35 sustainment and TR-3 software integration, as flagged in the 10-K, could pressure segment margins and compress free cash flow. Estimated probability: 35%. Impact: severe.
  2. Negative free cash flow persists: Q1 2026 free cash flow was negative USD1.2 billion and a failure to normalise through the year would undermine the dividend and buyback programme. Estimated probability: 30%. Impact: severe.
  3. PAC-3 delivery slippage: Slippage on the USD58.62 billion PAC-3 contract or related munitions framework agreements would push revenue and margin recognition into later periods. Estimated probability: 20%. Impact: moderate.
  4. NATO munitions demand normalises: A faster-than-expected easing of European munitions demand following the resolution of the Ukraine conflict would erode the multi-year munitions framework economics. Estimated probability: 25%. Impact: moderate.
  5. Aeronautics leadership transition risk: The 1 June 2026 handover of the Aeronautics presidency from Greg Ulmer to OJ Sanchez introduces execution risk on the largest reporting segment. Estimated probability: 15%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: Long-term equity investors with a minimum holding period of three to five years, a moderate risk tolerance, and a portfolio explicitly allocated to defence and industrial primes. Suitable for those seeking a combination of recurring US government contract revenue, dividend income, and backlog-supported visibility, and who can tolerate year-to-year volatility linked to programme milestones and US budget cycles.

Avoid if: Investors with a short-term trading horizon, a low tolerance for programme-execution and political-budget risk, or mandates that exclude defence-sector exposure. Speculative capital looking for rapid price re-rating should not hold this name, as the equity thesis depends on multi-year backlog conversion rather than near-term catalysts.

Recommendation

BUY - 67/100. The recommendation reflects hard contract catalysts - most notably the PAC-3 award and munitions framework agreements - combined with reaffirmed FY26 guidance and a defensible backlog of approximately USD174 billion, partially offset by F-35 execution risk disclosed in the 10-K and the negative Q1 2026 free cash flow print. The call would be upgraded towards a higher conviction tier on evidence of free cash flow normalisation through the remainder of 2026 and a clean Aeronautics leadership transition. The call would be downgraded on confirmation of a sustained F-35 sustainment overrun, a guidance cut at the next quarterly update, or a material deterioration in NATO munitions demand. At the current price of $582.74 the shares trade above our buy ceiling of $516.67: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $605.60, 4% above the current price of $582.74 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $516.67 - below this level the upside to the base-case target ($610.00) is at least 2x the downside to the bear case ($470.00), the minimum risk/reward we require before committing new capital.

HOLD

between $516.67 and $610.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $610.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 36%.

SELL

if A confirmed F-35 sustainment cost overrun requiring a 10-K disclosure update, a cut to FY26 net sales or earnings guidance, or the cancellation or material reduction of the PAC-3 contract, regardless of price - the bear target of $470.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 67/100. Trend versus prior report: Down.

10075502502026-08-012026-07-252026-06-282026-05-302026-04-27
Report dateConviction
2026-08-0129
2026-07-2564
2026-06-2864
2026-05-3076
2026-04-2782

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow was drawn from financial news wires reporting on Lockheed Martin's Q1 2026 earnings and FY26 guidance reaffirmation, defence industry press coverage of the PAC-3 contract and munitions framework agreements, public earnings calendar notes for the 23 April 2026 Q2 2026 release, and corporate press release distribution reporting the Aeronautics leadership transition.

Primary source types: SEC filings (Form 8-K dated 29 January 2026), company press releases distributed via PRNewswire, company investor relations materials, and earnings call and quarterly results announcements released by Lockheed Martin Corporation.

Key sources

Data correct as of 2026-08-01.